Your browser doesn't support javascript.
loading
The individual components of commercial isometamidium do not possess stronger trypanocidal activity than the mixture, nor bypass isometamidium resistance.
Eze, Anthonius A; Igoli, John; Gray, Alexander I; Skellern, Graham G; De Koning, Harry P.
Afiliação
  • Eze AA; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Medical Biochemistry Department, Faculty of Basic Medical Sciences, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria.
  • Igoli J; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; Department of Chemistry, College of Science, University of Agriculture, Makurdi, Nigeria.
  • Gray AI; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Skellern GG; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • De Koning HP; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom. Electronic address: harry.de-koning@glasgow.ac.uk.
Int J Parasitol Drugs Drug Resist ; 9: 54-58, 2019 04.
Article em En | MEDLINE | ID: mdl-30685630
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenantridinas / Tripanossomicidas / Resistência a Medicamentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenantridinas / Tripanossomicidas / Resistência a Medicamentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article